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Abstract
Background and Objectives: Sudden cardiac death is the most common cause of mortality in chronic kidney disease
patients, and it occurs mostly due to ventricular arrhythmias. In this study, we aimed at investigating the prevalence of
ventricular arrhythmia and the factors associated with its occurrence in nondialyzed chronic kidney disease patients.
Design, Setting, Participants and Measurements: This cross-sectional study evaluated 111 chronic kidney disease patients
(estimated glomerular filtration rate 34.7616.1 mL/min/1.73 m2, 57611.4 years, 60% male, 24% diabetics). Ventricular
arrhythmia was assessed by 24-hour electrocardiogram. Left ventricular hypertrophy (echocardiogram), 24-hour ambulatory
blood pressure monitoring, and coronary artery calcification (multi-slice computed tomography) and laboratory parameters
were also evaluated.
Results: Ventricular arrhythmia was found in 35% of the patients. Non-controlled hypertension was observed in 21%,
absence of systolic decency in 29%, left ventricular hypertrophy in 27%, systolic dysfunction in 10%, and coronary artery
calcification in 49%. Patients with ventricular arrhythmia were older (p,0.001), predominantly men (p = 0.009), had higher
estimated glomerular filtration rate (p = 0.03) and hemoglobin (p = 0.005), and lower intact parathyroid hormone (p = 0.024)
and triglycerides (p = 0.011) when compared to patients without ventricular arrhythmia. In addition, a higher left ventricular
mass index (p = 0.002) and coronary calcium score (p = 0.002), and a lower ejection fraction (p = 0.001) were observed
among patients with ventricular arrhythmia. In the multiple logistic regression analysis, aging, increased hemoglobin levels
and reduced ejection fraction were independently related to the presence of ventricular arrhythmia.
Conclusions: Ventricular arrhythmia is prevalent in nondialyzed chronic kidney disease patients. Age, hemoglobin levels and
ejection fraction were the factors associated with ventricular arrhythmia in these patients.
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Introduction
Sudden cardiac death is the single most common cause of
mortality in chronic kidney disease (CKD) patients undergoing
dialysis, accounting for 20–30% of deaths [1]. A large database
study has recently demonstrated that mortality attributed to
sudden cardiac death was 14-fold increased among dialysis
patients when compared to the general population, while the
proportion of deaths from other cardiovascular complications was
similar [2]. In CKD patients with documented coronary artery
disease, the decrement of glomerular filtration rate (GFR) was
shown to be a predictor of sudden cardiac death. Each 10 ml/min
decrease in GFR was associated with 11% increase in the risk for
sudden cardiac death. Additionally, while for patients with GFR
$60 ml/min the sudden cardiac death rate was 3.8 per 1000
patient-years, the rate rose to 7.3 for patients with GFR 15–
59 ml/min [3].
Epidemiological and observational studies have demonstrated
that overall incidence of sudden cardiac death in CKD population
is indeed greater than the incidence of coronary events [4],
suggesting a worrisome increase in the frequency of ventricular
arrhythmia, considered the foremost cause of sudden cardiac
death. Few studies, however, have investigated the occurrence of
ventricular arrhythmia in CKD populations. Data coming from
our group have previously demonstrated that the frequency of
ventricular arrhythmia was 48% in patients on hemodialysis [5],
45% in patients on peritoneal dialysis [6], and 30% among
incident kidney transplant recipients [7].
The traditional view of ventricular arrhythmias pathophysiology
posits a vulnerable diseased myocardium with a transient trigger.
In individuals without CKD, the substrate for a terminal
arrhythmia is most often an ischemic myocardium due to ruptured
arterial plaque, a focal myocardial scar or a reduced left
ventricular ejection fraction [8]. It is unknown whether this goes
true for CKD patients, who have more frequently diastolic
dysfunction, electrolyte disturbances and disorders in the mineral
metabolism [9]. Studies are required to better characterize the
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associated risk factors for ventricular arrhythmia in CKD
population.
Although cardiovascular mortality has shown to be substantially
elevated since the early stages of CKD, the occurrence of
ventricular arrhythmia and its associated risk factors has not been
so far investigated in CKD patients not requiring dialysis. Thus,
this study aimed at examining the prevalence of ventricular
arrhythmia and investigating the factors associated with ventric-
ular arrhythmia in nondialyzed CKD patients.
Materials and Methods
Population
A total of 111 non-dialyzed patients with CKD stages 2 to 5
were recruited from the outpatient clinic of the Federal University
of Sa˜o Paulo, Sa˜o Paulo, Brazil. Patients on treatment for at least 3
months were approached to participate in the study. Exclusion
criteria included age less than 18 years, presence of chronic
inflammatory disease, active malignancy, human immunodefi-
ciency virus, viral hepatitis, and chronic use of steroids. The
majority of the patients were on regular use of angiotensin-
converting enzyme inhibitors (81%) and diuretics (76%). Patients
were also under use of b-blockers (44%), calcium channel blockers
(40%), statins (32%) and angiotensin receptor blockers (22%).
Thirty five patients (33%) were using sevelamer, six patients (5%)
were taking calcium-based phosphate binders, and six patients
(5%) were taking calcitriol. Five patients were using erythropoiesis-
stimulating agents.
Written informed consent was obtained from all participants.
This study was reviewed and approved by the Ethics Advisory
Committee of the Federal University of Sao Paulo (approval
number 60806).
Study design and protocol
In this cross-sectional study all patients underwent clinical
history assessment, laboratory tests and cardiac evaluation within a
month. Demographic data, cardiovascular risk factors, comorbid-
ities and family history were also evaluated. Nutritional status was
evaluated by the subjective global assessment [10].
Laboratory tests
Blood samples were drawn in a 12-hour fasting state.
Biochemical and hematological parameters included serum
creatinine, hemoglobin, potassium, magnesium, lipid profile,
ionized calcium, phosphate, alkaline phosphatase, intact parathy-
roid hormone (iPTH - chemiluminescence imunoassay; Immulite;
DPC-Biermann, Bad Nauheim, Germany ; reference values 10 to
65 pg/ml) and Fibroblast growth factor 23 (FGF23 - ELISA
Kainos Laboratories, Tokyo, Japan). High-sensitivity C-reactive
protein was determined by immunochemiluminescence (CRP
Immunolite; Immunometric Assay, CA, USA) and interleukin-6
(IL-6) was measured using a commercially available enzyme-linked
immunosorbent assay (BD Biosciences Pharmingen, CA, USA).
Proteinuria was measured by obtaining 24-hour urine samples and
abnormal proteinuria was defined as urinary protein excretion
.150 mg/24 h. The glomerular filtration rate (eGFR) was
estimated by the CKD-EPI (Chronic Kidney Disease Epidemiol-
ogy Collaboration) equation [11]. The diagnosis and classification
of CKD were established as described elsewhere [12].
24-hour electrocardiogram
Ventricular arrhythmia and supraventricular arrhythmia were
evaluated by a 3-channel 24-hour electrocardiogram monitoring
(Cardios-LightH, Cardios, Sa˜o Paulo, Brazil). Ventricular arrhyth-
mia was defined as the presence of ventricular extra-systoles.
Echocardiogram
Two-dimensional color Doppler echocardiogram (PhilipsH HDI
5000, Royal Philips Electronics, Netherlands) was performed
according to the recommendations of the American Society of
Echocardiography [13]. Presence of left ventricular hypertrophy
was considered for a left ventricular mass index $134 g/m2
among men and .110 g/m2 among women. Systolic dysfunction
was defined as ejection fraction #55%.
24-hour ambulatory blood pressure monitoring
The 24-hour blood pressure monitoring was performed using
Dyna equipment (Cardios, Sa˜o Paulo, Brazil). Oscillometer was
adjusted to systolic blood pressure varying between 290 and 70,
and diastolic blood pressure varying between 180 and 45 mmHg,
and memory of up to 300 measurements/events. Blood pressure
(BP) measurements were obtained at intervals of 20 minutes
during the day and 30 minutes during sleep. Participants were
instructed to keep their habitual routine during the 24-h period
and to pause momentarily during each BP measurement. Dipping
(%) is defined by percent decrease in nighttime systolic-diastolic BP
blood pressure compared to daytime systolic-diastolic BP. When
patients exhibited dipping of less than 10%, they were defined as
non-dippers [14]. Hypertension was defined as blood pressure
greater than 140/90 mmHg or use of antihypertensive medica-
tion.
Coronary computed tomography
Patients underwent coronary artery calcification (CAC) quan-
tification by a multi-slice computed tomography scanner (Light-
SpeedH Pro 16; GE Healthcare, Milwaukee, WI, USA), using a
gantry rotation of 0.4 seconds, collimation of 2.5 mm (slice
thickness), and reconstruction time of six frames per second. A
calcium threshold of 130 or more Hounsfield Units was used. The
images were scored by a single radiologist blinded to the clinical
and biochemical aspects of the patient. As described by Agatston
et al. [15], the calcium score was determined by multiplying the
area of each calcified lesion by a weighting factor corresponding to
the peak pixel intensity for each lesion. The sum of each lesion of
all coronary arteries was used for analysis. Presence of calcification
was defined as CAC score .10 Agatston units (AU) and severe
calcification as CAC score $400 AU.
Statistical Analysis
Data were reported as mean and standard deviation (SD),
median and interquartile range, or frequencies (proportions).
Comparisons among continuous variables were done by Student’s
t-test and the Mann-Whitney U-test for normally distributed data
and skewed data, respectively. The study population was further
divided considering the presence of arrhythmia. Comparisons of
proportions were done by chi-square analysis or by the Fisher
exact test, when appropriate. The stepwise logistic regression
analysis was applied to assess the factors associated with the
presence of ventricular arrhythmia. All the variables with
significance at p,0.05 level in the univariate analysis were
considered in the multiple regression analysis. Statistical analysis
was performed using SPSS for Windows (version 19; SPSS,
Chicago, IL).
Ventricular Arrhythmia in CKD Patients
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Results
This study included 111 nondialyzed CKD patients, whose
majority was middle-aged men. Demographic, laboratorial and
cardiovascular data of the total population are summarized in
Table 1. Patients had been on treatment for a median time of 2
years. Most of them were in stage IIIa (15%), stage IIIb (30%) or
stage IV (41%) of CKD. The main CKD causes were hypertension
and diabetes. Overweight and obesity were found in 32% and
27% of the patients, respectively. Malnutrition was observed in
only 4% of the patients according to the subjective global
assessment. Twenty-four percent of the patients had diabetes.
Non controlled hypertension was observed in 21% of the patients,
while absence of systolic decency in 29%. Left ventricular
hypertrophy was found in 27% of the patients and systolic
dysfunction in 10%. Coronary artery calcification was observed in
49%, from which 46% had severe calcification.
Ventricular arrhythmia was found in 39 patients (35%), from
which 19 had also supraventricular arrhythmia. The median
number of extra systoles in the population with ventricular
arrhythmia was 51 (6–239) events/24 h. Table 2 depicts the
comparison between patients with and without ventricular
arrhythmia. Patients with ventricular arrhythmia were older,
predominantly men, had higher eGFR and hemoglobin, and
lower iPTH and triglycerides when compared to the patients
without ventricular arrhythmia. Of note, eGFR correlated with
hemoglobin (r = 0.422; p,0.01), iPTH (r =20.51, p,0.01) but
not with triglycerides (r = 0.16; p = 0.10). In addition, ventricular
arrhythmia group had higher left ventricular mass index and
coronary calcium score and lower ejection fraction (Figure 1).
When compared to patients without ventricular arrhythmia,
those with ventricular arrhythmia exhibited higher frequency of
systolic dysfunction (18% vs 6%; p= 0.037), ventricular hypertro-
phy (38% vs 21%; p= 0.047), and coronary artery calcification
(69% vs 39%; p= 0.004).
In the stepwise logistic regression analysis, age, hemoglobin, and
ejection fraction were the factors independently associated with
the presence of ventricular arrhythmia in nondialyzed CKD
patients (Table 3).
Discussion
According to the United States Renal Data System (USRDS)
database, the single largest cause of death is attributed to
arrhythmic disturbances. In fact, 26% of all-cause mortality
among dialysis patients is due to cardiac arrest, unknown cause or
arrhythmia [16]. The occurrence of ventricular arrhythmia and its
associated risk factors had not been so far described in CKD
patients in the initial stages of the disease. Herein we demonstrated
that the prevalence of ventricular arrhythmia is elevated among
CKD patients not yet requiring dialysis. In addition, we identified
aging, hemoglobin levels and ejection fraction as the factors
independently related to the presence of ventricular arrhythmia in
these patients.
Patients with end-stage renal disease have several factors that
could predispose to the development of ventricular arrhythmia. In
the general population, the association of aging with episodes of
fatal ventricular arrhythmia has been well recognized [17,18].
Accordingly, in the present study, we confirmed the association of
age with the occurrence of ventricular arrhythmia in patients with
CKD. In fact, the aging process contributes to changes in the
cardiovascular system such as increased arterial stiffness, increased
systolic ventricular wall stress, and diastolic dysfunction [19].
Those structural cardiac alterations over time, along with the
uremic cardiomyopathy, are potential contributors for the high
prevalence of arrhythmias in CKD patients.
Numerous studies in the general population have pointed out
men experience a higher rate of ventricular arrhythmia and
sudden death when compared to women [20–22]. In patients with
coronary artery disease and implantable cardioverter-defibrillators
it has been demonstrated that women were less likely to experience
ventricular tachycardia or ventricular fibrillation recurrences than
men [20]. Accordingly, in the present study, 77% of the patients
with ventricular arrhythmias were men. In fact, although the exact
physiologic mechanism that triggers this phenomenon is not clear,
it is likely that men have a greater propensity to ventricular
arrhythmias than women [17]. It has been suggested that some
differences in electrophysiologic properties related to sex hor-
mones may, at least in part, explain the gender-specific propensity
to ventricular arrhythmias [21,23]. In addition, some studies
advocate that gender differences in autonomic nervous system
Table 1. General characteristics of the study population.
(N=111)
Male [n(%)] 67 (60%)
Age (years) 57611.38
Black [n(%)] 21 (19%)
Follow up time (months) 21 (9–55)
Diabetes [n(%)] 27 (24%)
Tobacco use [n(%)] 57 (51%)
Body mass index (kg/m2) 26.865.26
Creatinine (mg/dL) 2.2660.84
eGFR (ml/min/1,73 m2) 34.7616.1
Proteinuria (g/24 h) 0.24 (0–0.79)
Hemoglobin (g/dL) 12.761.8
Potassium (mEq/L) 4.7 (4.3–5.1)
Magnesium (mEq/L) 1.9 (1.7–2.1)
Ionized calcium (mmol/L) 1.2860.05
Phosphate (mg/dL) 3.7860.72
Alkaline phosphatase (mg/dl) 81 (66–103)
PTH (pg/ml) 110 (63–193)
iFGF 23 (pg/ml) 47.3 (23.2–102.8)
CRP (mg/dl) 0.28 (0.12–0.77)
IL6 (pg/ml) 4.6 (2.7–8.4)
Total cholesterol (mg/dL) 184.2637.7
LDL cholesterol (mg/dL) 101628.2
HDL cholesterol (mg/dL) 51.5614.3
Triglycerides (mg/dL) 125 (99–206)
Median systolic pressure (mmHg) 125 (116.7–137)
Mean diastolic pressure (mmHg) 78.6610.9
Absence of systolic decency [n(%)] 32 (29%)
Non controlled hypertension [n(%)] 23 (21%)
Left ventricular mass index (g/m2) 102.3 (84.4–131.3)
Ejection fraction (%) 67 (62–70)
Calcium score (AU) 9 (0–334)
eGFR - estimated Glomerular Filtration Rate; iPTH - intact Parathyroid Hormone;
FGF23 - Fibroblast Growth Factor 23; CRP - C-Reactive Protein; IL6 - Interleukin-
6. Results in mean 6 SD, median (interquartiles) or proportions.
doi:10.1371/journal.pone.0066036.t001
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function, evaluated by variability in heart rate, could influence
ventricular tachyarrhythmias [24,25]. Actually, decreased heart
rate variability frequently observed among men has been
established as a significant risk factor for higher mortality in
general population as well as in dialysis population [26,27].
Corroborating with the above mentioned rationale, in the current
study, a lower heart rate variability was observed more frequently
among men when compared to women (14% vs 2%, p= 0.048,
respectively).
In the present study, increased hemoglobin levels were
independently associated with ventricular arrhythmia. Of note,
few patients were on ESA therapy. Several previous studies,
including CKD patients receiving ESA, on dialysis or not, have
demonstrated that higher hemoglobin has no benefit [28,29] or it
is even associated with cardiovascular complications and greater
risk of mortality [30,31] in these patients. In a retrospective study
with a cohort of 34,963 hemodialysis patients, each 1 g/dl increase
in the residual standard deviation was associated with a 33%
increase in the death rate [32]. Thus, a U-shaped relationship
between hemoglobin levels and clinical outcomes has been
suggested in this particular group of patients [33,34]. More studies
are necessary to explore the mechanistic explanation for these
findings.
The traditional view of ventricular arrhythmia pathophysiology
postulates a vulnerable diseased myocardium with a transient
arrhythmic trigger [8,9,17]. Left ventricular hypertrophy and
systolic dysfunction are highly prevalent in asymptomatic patients
with end-stage renal disease, which sets a high background risk of
arrhythmias in this population [7,35]. The association between
poor systolic function and ventricular arrhythmia or sudden
cardiac death has been demonstrated in studies including both
general [36,37] and CKD [38,39] population. Accordingly, a
reduced ejection fraction was independently associated with the
presence of ventricular arrhythmia in the present study.
Available literature suggests a relationship between left ventric-
ular hypertrophy and cardiac arrhythmia in patients on hemodi-
alysis [4,5]. The myocardial fibrosis and hypertrophy provide
additional substrate for an increased electric instability and may
then contribute to an increased risk of ventricular arrhythmia and
sudden cardiac death in uremic patients [37]. Paoletti et al.
indicated that left ventricular hypertrophy, and particularly its
progression, was the strongest predictive factor of lethal arrhyth-
mias in uremic patients [40]. Of note, patients with ventricular
arrhythmia in the present study had higher left ventricular mass
index and a higher frequency of left ventricular hypertrophy.
It has been already established that coronary artery calcification
is highly prevalent in dialysis patients as well as in nondialyzed
CKD patients [41–44]. Not surprisingly, a high prevalence of
coronary artery calcification was found in our study sample. We
have previously demonstrated the straight association between
vascular calcification and cardiovascular events in nondialyzed
CKD patients [45], which is in line with the finding by other
investigators [46,47]. In the current study, coronary calcium score
and the frequency of coronary artery calcification were both
higher among patients with ventricular arrhythmia, when
compared to those without this cardiac complication. The impact
of the presence of ventricular arrhythmia on hard outcomes
remains to be further investigated.
There is evidence in the literature that the protein-energy
malnutrition might increases the risk of prolonged QT interval,
ventricular arrhythmias and sudden death [48]. The only measure
that could support this rationale herein is the lower triglycerides
level found in the group of patients with ventricular arrhythmia.
However, since only 4% of the patients in the current study were
malnourished according to the subjective global assessment, this
supposition is unlikely in this study. Another explanation for the
lower triglycerides in the group with arrhythmias could be that
Figure 1. Cardiovascular parameters according to the presence
of ventricular arrhythmia. Left Ventricular Mass Index (A), Calcium
Score (B) and Ejection fraction (C) in patients with and without
ventricular arrhythmia.
doi:10.1371/journal.pone.0066036.g001
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Table 2. Comparison between patients with and without ventricular arrhythmia (VA).
Without VA With VA p
Number 72 39
Male [n(%)] 37 (51%) 30 (77%) 0.009
Age (years) 54611 6269.5 ,0.001
White [n(%)] 42 (58%) 14 (36%) 0.07
Follow up time (months) 15.5 (8.2–55.5) 24 (11–55) 0.61
Diabetes [n(%)] 19 (26%) 8 (20%) 0.49
Tobacco use [n(%)] 33 (46%) 24 (61%) 0.11
Body mass index (kg/m2) 26.965.7 26.864.2 0.92
Creatinine (mg/dL) 2.460.9 1.9760.67 0.007
eGFR (ml/min/1,73 m2) 32.4615.9 39.5615.8 0.03
Proteinuria (g/24 h) 0.37 (0–0.9) 0 (0–0.38) 0.02
Hemoglobin (g/dL) 12.461.8 13.461.61 0.005
Potassium (mEq/L) 4.8 (4.4–5.1) 4.7 (4.2–5.2) 0.30
Magnesium (mEq/L) 1.9 (1.72–2.1) 1.9 (1.7–2.1) 0.89
Ionized calcium (mmol/L) 1.2760.05 1.2860.05 0.34
Phosphorus (mg/dL) 3.8560.74 3.660.68 0.18
Alkaline phosphatase (mg/dl) 78.5 (62–100.5) 87 (75–112) 0.07
iPTH (pg/ml) 132.5 (74.5–225.5) 94 (56–144) 0.02
FGF 23 (pg/ml) 45.4 (27.9–109) 63,1 (15.2–89.9) 0.68
CRP (mg/dl) 0.25 (0.09–0.69) 0.41 (0.15–0.85) 0.18
IL6 (pg/ml) 4.4 (2.2–8.5) 5.4 (3.0–8.0) 0.28
Total cholesterol (mg/dL) 185.6637.7 181.3638.03 0.57
LDL cholesterol (mg/dL) 101.3630.1 100.4624.4 0.87
HDL cholesterol (mg/dL) 51613.1 52.8617.7 0.53
Triglycerides (mg/dL) 139 (106–215.7) 110 (72–161) 0.01
Median systolic pressure (mmHg) 125.5 (117–138) 125 (115.7–134.2) 0.75
Mean diastolic pressure (mmHg) 79.2610.7 77.7611.3 0.50
Absence of systolic decency [n(%)] 21 (30%) 11 (29%) 0.56
Left ventricular mass index (g/m2) 95 (81–120) 119 (91–136) 0.002
Ejection fraction (%) 67 (63–72) 65 (58–68) 0.001
Calcium score (AU) 0 (0–168.7) 213 (1–671) 0.002
eGFR - estimated Glomerular Filtration Rate; iPTH - intact Parathyroid Hormone; FGF23 - Fibroblast Growth Factor 23; CRP - C-Reactive Protein; IL6 - Interleukin-6. Results
in mean 6 SD, median (interquartiles) or proportions.
doi:10.1371/journal.pone.0066036.t002
Table 3. Stepwise logistic regression analysis: Variables in the Equation.
Variables Sig Exp (B) Lower 95%CI for Exp B Upper 95%CI for Exp B
Step 1
Age 0.001 1.076 1.030 1.124
Step 2
Age 0.002 1.078 1.028 1.129
Ejection fraction 0.008 0.936 0.891 0.983
Step 3
Age 0.004 1.076 1.024 1.130
Ejection fraction 0.008 0.936 0.891 0.983
Hemoglobin 0.021 1.391 1.052 1.839
Variables included in the model: age, gender, estimated glomerular filtration rate, proteinuria (g/24 h), hemoglobin, intact parathyroid hormone, triglycerides, left
ventricular mass index, ejection fraction and calcium score.
doi:10.1371/journal.pone.0066036.t003
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these patients also have higher eGFR. However no correlation
between these variables was observed in the present study. More
studies are necessary to elucidate the physiopathology aspects
involving such relationships.
Clinical studies in chronic dialysis patients have suggested a U-
shaped relationship between PTH and sudden death, probably
due to arrhythmia [49,50]. In the present study, PTH levels were
lower in patientes with ventricular arrhythmias. However, this
group of patients had also better renal function, and unexpected
findings were the higher eGFR and proteinuria in the group of
patients with ventricular arrhythmia. According to the literature,
both lower eGFR and the presence of proteinuria are associated
with poorer cardiovascular outcomes in CKD patients [51].
Proteinuria has also been described as related to prolonged QT
interval and other electrocardiographic abnormalities [52]. Thus,
we cannot exclude the possibility of a survival bias due to the fact
patients with worse renal function and ventricular arrhythmia may
have passed away. Another possible explanation could be that
eGFR does not accurately reflect the concentration of other
different uremic solutes such as indoxyl sulfate, hippurate, and
asymmetric dimethylarginine [53,54], that are known to be linked
to vascular damage and worse clinical outcomes [53].
This study has some limitations to be considered, such as the
relatively small sample of prevalent CKD patients, what could
introduce survival bias. Moreover, the cross-sectional design of the
study does not allow us to evaluate the cause-effect relationship to
derive conclusions.
In the present study, we concluded that ventricular arrhythmia
was prevalent in nondialyzed CKD patients. Aging, increased
hemoglobin levels and reduced ejection fraction were the factors
independently associated with the presence of ventricular
arrhythmia in these patients. To the best of our knowledge, this
is the first study to evaluate the frequency of ventricular
arrhythmia and its relationship with clinical, laboratorial and
cardiovascular parameters in nondialyzed CKD patients. We
believe that the present findings can contribute to improve the
understanding in this field and draw attention to the need of an
early diagnosis and treatment of ventricular arrhythmia during the
nondialysis stages of the disease, in order to reduce its incidence
and consequent sudden death rate in CKD population.
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